(11S,14R)-N-[(4-carbamimidoylphenyl)methyl]-3,13,22-trioxo-14-(phenylmethane)sulfonamido-1,4,12,21,24-pentaazatetracyclo[22.2.2.1^{5,9}.1^{16,20}]triaconta-5(30),6,8,16,18,20(29)-hexaene-11-carboxamide; trifluoroacetic acid (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (11S,14R)-N-[(4-carbamimidoylphenyl)methyl]-3,13,22-trioxo-14-(phenylmethane)sulfonamido-1,4,12,21,24-pentaazatetracyclo[22.2.2.1^{5,9}.1^{16,20}]triaconta-5(30),6,8,16,18,20(29)-hexaene-11-carboxamide; trifluoroacetic acid's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
(11S,14R)-N-[(4-carbamimidoylphenyl)methyl]-3,13,22-trioxo-14-(phenylmethane)sulfonamido-1,4,12,21,24-pentaazatetracyclo[22.2.2.1^{5,9}.1^{16,20}]triaconta-5(30),6,8,16,18,20(29)-hexaene-11-carboxamide; trifluoroacetic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Vitamin K-dependent protein C Protein (Entity type)	Ki
(11S,14R)-N-[(4-carbamimidoylphenyl)methyl]-3,13,22-trioxo-14-(phenylmethane)sulfonamido-1,4,12,21,24-pentaazatetracyclo[22.2.2.1^{5,9}.1^{16,20}]triaconta-5(30),6,8,16,18,20(29)-hexaene-11-carboxamide; trifluoroacetic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Plasma kallikrein Protein (Entity type)	Ki
(11S,14R)-N-[(4-carbamimidoylphenyl)methyl]-3,13,22-trioxo-14-(phenylmethane)sulfonamido-1,4,12,21,24-pentaazatetracyclo[22.2.2.1^{5,9}.1^{16,20}]triaconta-5(30),6,8,16,18,20(29)-hexaene-11-carboxamide; trifluoroacetic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Plasminogen Protein (Entity type)	Ki
(11S,14R)-N-[(4-carbamimidoylphenyl)methyl]-3,13,22-trioxo-14-(phenylmethane)sulfonamido-1,4,12,21,24-pentaazatetracyclo[22.2.2.1^{5,9}.1^{16,20}]triaconta-5(30),6,8,16,18,20(29)-hexaene-11-carboxamide; trifluoroacetic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Coagulation factor X Protein (Entity type)	Ki
(11S,14R)-N-[(4-carbamimidoylphenyl)methyl]-3,13,22-trioxo-14-(phenylmethane)sulfonamido-1,4,12,21,24-pentaazatetracyclo[22.2.2.1^{5,9}.1^{16,20}]triaconta-5(30),6,8,16,18,20(29)-hexaene-11-carboxamide; trifluoroacetic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Prothrombin Protein (Entity type)	Ki